Site Search

Site Search

Displaying results 411 - 420 of 893

Project reporting documents

Content | 21/11/2018
expand all IMI1 Periodic Report template (revised February 2020) pdf | Word For the last reporting period, a single report combining the final report and the periodic report for the last period should be submitted (see template below). Deliverable template (revised January 2020) ...

Guidelines on engaging with regulators

Content | 21/11/2018
Many IMI projects are developing tools and methods with a potential regulatory impact, such as tests and measures to evaluate medicines safety or efficacy, or alternative clinical trial designs. For this reason, we encourage all projects to seek regulatory engagement as early as ...

Open access and data management for projects

Content | 21/11/2018
This page provides an overview of the rules and guidelines related to open access to publications and research data management that apply to IMI2 projects. Requirements for open access to publications and useful resources Article 29.2 of the IMI2 JU Grant Agreement details the ...

Project dissemination

Content | 21/11/2018
IMI1 project dissemination IMI1 project partners have a contractual obligation to disseminate the foreground (Art. II.34 of the Annex II – General Conditions of the Grant Agreement). For more information please check our guidelines on dissemination for IMI1 projects. IMI2 project ...

Project communications

Content | 21/11/2018
Communication is an important activity for all IMI projects, a fact that is recognised in the legislation creating IMI and the model Grant Agreements for both IMI1 and IMI2 projects. We have created an IMI Project Communications Guide which sets out the rules that all IMI ...

Taking a tailored approach to type 2 diabetes

News | 16/11/2018 |
IMI's RHAPSODY project researchers have split type 2 diabetes into subgroups and are working on a tool to personalise treatment for the disease. Their aim is to help patients get the best possible care for their specific condition and cut public health costs.
Illustrative image

Fast, effective treatment for autoimmune rheumatic diseases

News | 12/10/2018 |
Autoimmune rheumatic diseases like rheumatoid arthritis, lupus and scleroderma are debilitating and occasionally life-threatening. IMI's PRECISESADS project aims to improve treatment by getting the right therapies to the right patients, fast.
Illustrative image

Remote monitoring boost for long-term patients

News | 11/10/2018 |
Patients with long-term medical conditions, such as depression, multiple sclerosis and epilepsy, need regular monitoring, but having to visit the clinic frequently for tests can be a problem. IMI's RADAR-CNS project is aiming to implement real-time, on-demand monitoring through ...
Wearable device